Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Resistance in hepatitis B virus].

Enfermedades infecciosas y microbiologia clinica - 1 May 2008

Sheldon Julie, Sarmento E Castro Rui, Soriano Vicente

Abstract excerpt

The development hepatitis B virus (HBV) polymerase inhibitors has revolutionised the treatment of chronic HBV infection. However, the emergence of resistance mutations can compromise their clinical efficacy and it is mandatory to know the mechanisms of these resistances, its clinical implications...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Products, pol
Share to Drug Resistance, Multiple, Viral
Share to Adenine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Guanine

Share to Lamivudine

Share to Organophosphonates

Share to Reverse Transcriptase Inhibitors

Share to Tenofovir

Source

Identifiers

PMID: 19100231
DOI: 10.1016/s0213-005x(08)76519-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19100231-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Resistance in hepatitis B virus].PMID 19100231Read ↗

Treatment for hepatitis B in patients with drug resistanceSemantic proximity Read ↗

[Hepatitis B and C virus antiviral resistance].Semantic proximity Read ↗

[Management of antiviral-resistant chronic hepatitis B virus infection].Semantic proximity Read ↗

Management and prevention of drug resistance in chronic hepatitis B.Semantic proximity Read ↗

[Mechanisms of drug resistance in hepatitis viruses B and C].Semantic proximity Read ↗

[Investigation of baseline antiviral resistance in treatment-naive chronic hepatitis B cases].Semantic proximity Read ↗

Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002-2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment.Semantic proximity Read ↗

Antiviral resistance and hepatitis B therapy #Semantic proximity Read ↗

Antiviral‐resistant hepatitis B virus: can we prevent this monster from growing?Semantic proximity Read ↗

[RESISTANCE OF HCV TO NEW DIRECT ACTING ANTIVIRALS].Semantic proximity Read ↗

Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade.Semantic proximity Read ↗

Molecular characterization of a novel entecavir mutation pattern isolated from a multi-drug refractory patient with chronic hepatitis B infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.